GlassScriptPhysician profile
Marcus A Mayus
NPI 1073734935
$28,915.06
in general payments reported to CMS, 2019-2025
82 companies · $4,860 in 2025
The $4,860 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $2,933 · 2021: $3,971 · 2022: $4,640 · 2023: $5,324 · 2024: $5,387 · 2025: $4,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,444.02 |
| Education | $126.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,985.17 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,096.65 | 2019-2025 | Breztri, Farxiga, Fasenra |
| Pfizer INC. | $1,593.90 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,577.82 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $1,078.86 | 2019-2025 | Verquvo, Capvaxive, Belsomra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $833.08 | 2022-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $786.79 | 2019-2025 | Jardiance, Ofev, Tradjenta |
| Exact Sciences Corporation | $767.93 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $756.70 | 2019-2025 | Xifaxan |
| Novo Nordisk INC | $704.66 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $569.46 | 2019-2025 | |
| Bausch Health US, LLC | $552.31 | 2019-2025 | Aplenzin, Wellbutrin |
| Sumitomo Pharma America, INC. | $526.74 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $522.78 | 2019-2023 | |
| Allergan, INC. | $522.59 | 2019-2020 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $485.30 | 2019-2025 | Veozah, Myrbetriq |
| Axsome Therapeutics, INC. | $454.93 | 2025 | Auvelity, Symbravo |
| Abbott Laboratories | $448.87 | 2022-2024 | Freestyle Libre 3, Navitor |
| Eisai INC. | $444.38 | 2020-2022 | |
| Lilly USA, LLC | $420.50 | 2019-2025 | Zepbound, Jardiance, Emgality |
| Takeda Pharmaceuticals U.S.A., INC. | $403.41 | 2019-2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $400.72 | 2019-2024 | Spravato |
| Amgen INC. | $395.46 | 2020-2025 | Repatha, Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $394.72 | 2020-2025 | Camzyos, Eliquis |
| Ironwood Pharmaceuticals, INC | $376.22 | 2019-2023 | Linzess |
| Idorsia Pharmaceuticals US INC | $344.85 | 2022-2024 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $333.86 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $275.27 | 2021-2025 | |
| Lundbeck LLC | $255.29 | 2022-2024 | Rexulti |
| Ardelyx, INC. | $253.75 | 2024-2025 | Ibsrela |
| Nestle Healthcare Nutrition INC. | $250.94 | 2020-2023 | |
| Corium, LLC | $241.14 | 2022-2025 | Azstarys |
| Sunovion Pharmaceuticals INC. | $213.87 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $176.17 | 2020-2024 | Rexulti |
| Amneal Pharmaceuticals LLC | $154.98 | 2020-2024 | Rytary |
| Teva Pharmaceuticals USA, INC. | $146.86 | 2019-2021 | |
| Antares Pharma, INC. | $143.58 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Scilex Pharmaceuticals INC. | $136.40 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $124.72 | 2021 | |
| Esperion Therapeutics, INC. | $120.70 | 2022-2024 | Nexletol |
| Jazz Pharmaceuticals INC. | $116.66 | 2020-2022 | |
| Upsher-Smith Laboratories LLC | $97.01 | 2022-2023 | |
| Mylan Specialty L.P. | $90.28 | 2020-2021 | |
| Almatica Pharma LLC | $87.68 | 2021-2025 | Loreev Xr |
| Ibsa Pharma INC. | $73.13 | 2020-2024 | Tirosint, Licart, Licart |
| Romark Laboratories, Lc | $70.99 | 2019 | |
| Adlon Therapeutics L.P. | $69.12 | 2020-2021 | |
| Qol Medical, LLC | $68.42 | 2022 | |
| Genentech USA, INC. | $68.35 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $65.04 | 2023-2025 | Azmiro, Horizant |
| Hikma Pharmaceuticals USA | $64.71 | 2019 | |
| Currax Pharmaceuticals LLC | $56.81 | 2020-2025 | Contrave |
| Medtronic, INC. | $53.89 | 2024 | Corevalve Evolut R |
| Biohaven Pharmaceutical Holding Company LTD. | $43.62 | 2022 | |
| Phathom Pharmaceuticals, INC. | $35.47 | 2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $33.40 | 2023 | Evkeeza |
| Inspire Medical Systems, INC. | $31.32 | 2023 | Inspire |
| Impel Pharmaceuticals INC. | $30.64 | 2023 | Trudhesa |
| Baxter Healthcare | $29.89 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Mission Pharmacal Company | $29.11 | 2019 | |
| Avion Pharmaceuticals | $27.90 | 2020 | |
| Biogen, INC. | $26.02 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $24.35 | 2023 | Qelbree |
| Acorda Therapeutics, INC | $24.33 | 2019 | |
| Collegium Pharmaceutical, INC. | $24.20 | 2023 | Xtampza |
| Cleerly, INC. | $24.03 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Medicomp INC | $20.75 | 2024 | Telepatch Cardiac Monitor |
| Zyla Life Sciences, INC. | $20.40 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $20.24 | 2024 | Opsumit |
| Dexcom, INC. | $20.08 | 2025 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $19.28 | 2022 | |
| Optinose US, INC. | $19.00 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $18.78 | 2025 | Rhythm Express |
| Alnylam Pharmaceuticals INC. | $17.76 | 2025 | Amvuttra |
| Medtronic Minimed, INC. | $17.31 | 2020 | |
| Avanir Pharmaceuticals, INC. | $16.98 | 2019 | |
| Horizon Therapeutics Plc | $15.85 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $15.31 | 2024 | Arcalyst |
| Endo Pharmaceuticals INC. | $15.22 | 2022 | |
| Phadia US INC. | $14.11 | 2025 | Immunocap |
| Sanofi Pasteur INC. | $13.43 | 2019 | |
| Nabriva Therapeutics, Plc | $11.86 | 2020 |
Drugs and devices associated with these payments
Ubrelvy $1,680Qulipta $1,568Vraylar $1,222Nurtec Odt $953Breztri $854Verquvo $781Cologuard Collection Kit $768Caplyta $711Zavzpret $642Gemtesa $527Xifaxan $512Auvelity $424Leqvio $378Jardiance $336Farxiga $335Wegovy $311Rexulti $302Aplenzin $296Paxlovid $288Quviviq $286Trelegy Ellipta $271Eliquis $255Ibsrela $254Ozempic $251Shingrix $231Rybelsus $230Wellbutrin $229Arexvy $217Comirnaty $208Freestyle Libre 3 $205Camzyos $203Azstarys $198Zepbound $175Emgality $152Xyosted $144Repatha $140Kerendia $137Capvaxive $123Abrysvo $114Prevnar 20 $114Entresto $111Nexletol $96.71Mounjaro $96.07Linzess $95.88Fasenra $92.77Otezla $90.52Belsomra $88.97Veozah $82.78Gardasil 9 $70.04Zenpep $68.96Rytary $62.64Synthroid $62.47Tosymra $60.96Zembrace Symtouch $60.96Navitor $55.61Corevalve Evolut R $53.89Tirosint $53.85Licart $53.85Lagevrio $48.48Azmiro $47.04Contrave $45.30Steglatro $42.10Voquezna $35.47Evkeeza $33.40Trintellix $33.05Vascepa $32.59Inspire $31.32Symbravo $31.10Trudhesa $30.64Hillrom - Carnation Ambulatory Monitor $29.89Krystexxa $29.74Ofev $28.80Zurzuvae $26.02Qelbree $24.35Xtampza $24.20Cleerly Ischemia $24.03Cleerly Labs $24.03Gardasil $23.95Loreev Xr $23.02Myrbetriq $22.99M-M-R II $22.80Telepatch Cardiac Monitor $20.75Tradjenta $20.49Opsumit $20.24Dexcom G6 Transmitter $20.08Xhance $19.00Rhythm Express $18.78Horizant $18.00Amvuttra $17.76Arcalyst $15.31Nocdurna $15.14Tlando $15.14Spravato $14.66Immunocap $14.11
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Mayus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.